H. Schwinn

发表

Molecular defects in coagulation Factor VIII and their impact on Factor VIII function

C. Hauser, D. Josić, S. Pipe, 2002, Vox sanguinis.

Application of compact porous tubes for preparative isolation of clotting factor VIII from human plasma.

D. Josić, A. Podgornik, P. Raspor, 1997, Journal of chromatography. A.

Issues in the development of medical products based on human plasma.

D. Josić, L. Biesert, A. Štrancar, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Application of compact porous disks for fast separations of biopolymers and in-process control in biotechnology.

D. Josić, A. Štrancar, H. Schwinn, 1996, Analytical chemistry.

Use of compact, porous units with immobilized ligands with high molecular masses in affinity chromatography and enzymatic conversion of substrates with high and low molecular masses.

Y. Lim, D. Josić, A. Podgornik, 1998, Journal of chromatography. A.

Manufacture and in vitro Characterization of a Solvent/Detergent‐Treated Human Plasma

P. Hellstern, H. Schwinn, H. Sachse, 1992, Vox sanguinis.

Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay.

D. Josić, M. Shima, A. Sarafanov, 2002, Analytical biochemistry.

Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.

D. Josić, M. Shima, A. Sarafanov, 1999, Journal of chromatography. A.

Removal of parvovirus B19 from contaminated factor VIII during fractionation

W. Stolz, T. Schwarz, M. Roggendorf, 1991, Journal of medical virology.

Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity.

D. Josić, A. Klukowska, L. Biesert, 2000, Thrombosis research.

Improved virus safety and purity of a chromatographically produced factor IX concentrate by nanofiltration.

D. Josić, L. Biesert, H. Schwinn, 1995, Journal of chromatography. B, Biomedical applications.

Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography.

D. Josić, A. Štrancar, H. Schwinn, 1994, Journal of chromatography. B, Biomedical applications.

Clotting factors and hepatitis A

W. Gerlich, T. Walsh, D. Shouval, 1992, The Lancet.

Comparison of the properties of phospholipid surfaces formed on HPA and L1 biosensor chips for the binding of the coagulation factor VIII.

D. Josić, M. Shima, E. Behre, 2001, Journal of chromatography. A.

Size-exclusion chromatography of plasma proteins with high molecular masses.

D. Josić, P. Schulz, H. Schwinn, 1998, Journal of chromatography. A.

Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis.

I. Chaudry, Ping Wang, Y. Lim, 2002, Critical care medicine.

Orthopaedics and Haemophilia

M. Blombäck, G. Lüchters, F. Mandelli, 1981 .

Degradation Products of Factor VIII Which Can Lead to Increased Immunogenicity

Horst Schwinn, Y. Lim, A. Buchacher, 1999, Vox Sanguinis.

Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography.

Alois Jungbauer, Djuro Josic, Horst Schwinn, 2002, Journal of chromatography. A.

Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.

H. Schwinn, A. Smith, D. Wolter, 1989, Arzneimittel-Forschung.

Continuous Removal of Protein Aggregates by Annular Chromatography

A Jungbauer, D. Josić, A. Jungbauer, 2001, Biotechnology progress.

Affinity chromatography of human blood coagulation factor VIII on monoliths with peptides from a combinatorial library

D. Josić, A. Jungbauer, R. Hahn, 2000 .

Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent--detergent method.

D. Josić, P. Raspor, A. Štrancar, 1994, Journal of chromatography. A.

Molecular basis for different ability of low-density and high-density lipoproteins to support activity of the intrinsic Xase complex.

Djuro Josic, Horst Schwinn, D. Josić, 2002, Thrombosis research.

High-performance capillary electrophoresis for in-process control in the production of antithrombin III and human clotting factor IX.

D. Josić, A. Buchacher, J. Choromanski, 1998, Journal of chromatography. A.

Production of highly purified clotting factor IX by a combination of different chromatographic methods.

D. Josić, H. Schwinn, L. Hoffer, 1999, Journal of chromatography. A.

Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.

D. Josić, H. Schwinn, F. Bal, 1993, Journal of chromatography.

[Factor VIII concentrate, highly purified and heated in solution (author's transl)].

N. Heimburger, H. Schwinn, G. Lüben, 1981, Arzneimittel-Forschung.

A solvent I detergent treated, pasteurised and highly purified factor VIII concentrate.

D. Josić, W. Gehringer, H. Schwinn, 1994, Arzneimittel-Forschung.

Molecular modifications in factor VIII concentrates produced from different plasma pools.

Y. Lim, D. Josić, M. Shima, 2001, Thrombosis research.

A comparable Wikipedia corpus: from wiki syntax to POS tagged XML

Noah Bubenhofer, Stefanie Haupt, Horst Schwinn, 2011 .

A Factor VIII Concentrate, Highly Purified and Heated in Solution

N. Heimburger, H. Schwinn, G. Kumpe, 1981 .

Manufacturing and down scaling process for a virus-inactivated pooled human plasma

D. Josić, H. Schwinn, R. Schütz, 1996 .

Peptide affinity chromatography of human clotting factor VIII. Screening of the vWF-binding domain.

D. Josić, A. Jungbauer, E. Schallaun, 1998, Journal of chromatography. B, Biomedical sciences and applications.